A Study in Healthy Men to Test How BI 1569912 is Processed in the Body

NCT06520553 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 1569912 (C-14)
DRUG: BI 1569912 (C-13)

Sponsor

Boehringer Ingelheim